FDA Approvals, News & UpdatesKidney CancerNewsworthy
The use of Opdivo with Yervoy is the first immunotherapy combination therapy approved by the FDA for patients with kidney cancer.
Kidney CancerPatient Stories
Richard J. Smith tells his experience with kidney cancer, which led him to lose weight, be more active, and live a healthy life.
By Laura Morgan
Kidney cancers are among the 10 most common cancers in men and women in the United States. According to the American Cancer Society, about 62,700 new cases of kidney cancer will be diagnosed in the United States in 2016, and 14,240 people will die from the disease.
Results 1 - 7 of 7